American Funds®

GROWTH & INCOME FUNDS

SM

220 Total Holdings:
As of 12/31/14 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 220
Asset Type
AXA SA Equity 9,919,200 $229,099,119.00 2.36%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 51,771,506 $228,453,713.00 2.36%
Novartis AG Equity 2,427,000 $223,205,084.00 2.3%
EDP - Energias de Portugal, SA Equity 49,450,000 $191,244,268.00 1.97%
Orange SA Equity 10,270,000 $174,654,424.00 1.8%
Sun Hung Kai Properties Ltd. Equity 10,686,402 $161,593,419.00 1.67%
Royal Dutch Shell PLC, Class B Equity 4,645,000 $159,573,916.00 1.65%
British American Tobacco PLC Equity 2,780,300 $151,064,354.00 1.56%
Power Assets Holdings Ltd. Equity 15,566,500 $150,381,657.00 1.55%
Enbridge Inc. Equity 2,728,132 $140,281,120.00 1.45%
AstraZeneca PLC Equity 1,905,000 $134,008,385.00 1.38%
Banco Santander, SA Equity 14,325,368 $119,786,209.00 1.24%
Suncorp Group Ltd. Equity 10,492,000 $119,557,994.00 1.23%
Wolseley PLC Equity 2,084,684 $118,677,620.00 1.22%
TOTAL SA Equity 2,077,896 $107,134,696.00 1.11%
All Holdings: 1 - 15 of 220

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

  1. Excludes certain securities in initial period of acquisition.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.